Idiopathic Pulmonary Fibrosis
|
0.160 |
GeneticVariation
|
disease |
BEFREE |
Furthermore, genetic variants of TOLLIP, MUC-5B, and other genes associated with a differential response to treatment and with the development and/or the prognosis of IPF are reported.
|
30526140 |
2019 |
Idiopathic Pulmonary Fibrosis
|
0.160 |
GeneticVariation
|
disease |
BEFREE |
Furthermore, genetic variants of TOLLIP, MUC5B, and other genes are associated with a differential response to treatment and with the development and/or the prognosis of IPF.
|
29408012 |
2018 |
Idiopathic Pulmonary Fibrosis
|
0.160 |
GeneticVariation
|
disease |
BEFREE |
We measured two common single-nucleotide polymorphisms associated with IPF (MUC5B rs35705950 and TOLLIP rs5743890) and telomere length in peripheral blood leucocytes, and assessed their associations with chronic hypersensitivity pneumonitis risk, survival, and clinical, radiographic, and pathological features.
|
28648751 |
2017 |
Idiopathic Pulmonary Fibrosis
|
0.160 |
GeneticVariation
|
disease |
BEFREE |
A recent pharmacogenetic analysis of patients enrolled in an IPF clinical trial identified a variant within TOLLIP to be associated with differential response to N-acetylcysteine therapy.
|
27253772 |
2016 |
Idiopathic Pulmonary Fibrosis
|
0.160 |
GeneticVariation
|
disease |
BEFREE |
Polymorphisms in the MUC5B promoter, TOLLIP, and nine additional genetic loci have been associated with idiopathic pulmonary fibrosis (IPF) within non-Hispanic white populations.
|
25275363 |
2015 |
Idiopathic Pulmonary Fibrosis
|
0.160 |
GeneticVariation
|
disease |
GWASCAT |
Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study.
|
24429156 |
2013 |
Idiopathic Pulmonary Fibrosis
|
0.160 |
GeneticVariation
|
disease |
GWASDB |
Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study.
|
24429156 |
2013 |
Idiopathic Pulmonary Fibrosis
|
0.160 |
AlteredExpression
|
disease |
BEFREE |
These associations and the reduced expression of TOLLIP in patients with IPF who carry TOLLIP SNPs emphasise the importance of this gene in the disease.
|
24429156 |
2013 |
Lung Diseases, Interstitial
|
0.100 |
GeneticVariation
|
group |
GWASDB |
Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis.
|
23583980 |
2013 |
Tuberculosis
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
Evaluation of TLR2, TLR4, and TOLLIP polymorphisms for their role in tuberculosis susceptibility.
|
29924447 |
2018 |
Tuberculosis
|
0.040 |
Biomarker
|
disease |
BEFREE |
To identify functional TOLLIP variants and evaluate the role of TOLLIP variation on innate and adaptive immune responses to mycobacteria and susceptibility to tuberculosis.
|
28463648 |
2017 |
Tuberculosis
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
Multiple SNPs in IL4 and TOLLIP were associated with TB (P < 0.05).
|
25521228 |
2015 |
Tuberculosis
|
0.040 |
Biomarker
|
disease |
BEFREE |
These data demonstrate that TOLLIP has an anti-inflammatory effect on TLR signaling in humans and that TOLLIP deficiency is associated with an increased risk of tuberculosis.
|
22778396 |
2012 |
Rhinovirus infection
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Both IL6 and TOLLIP polymorphisms but not TNFA or IL1B influenced Rhinovirus detection in the nostrils of voluntaries.
|
31350695 |
2019 |
Asthma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Tollip genetic variation has been associated with airflow limitation in asthma subjects and Tollip expression.
|
29393212 |
2018 |
Latent Tuberculosis
|
0.020 |
Biomarker
|
disease |
BEFREE |
This study was designed to investigate potential associations between the polymorphisms in TLR2, TLR4, and TOLLIP and susceptibility to latent tuberculosis infection (LTBI) or subsequent PTB in a Chinese Han population.
|
29924447 |
2018 |
nervous system disorder
|
0.020 |
Biomarker
|
group |
BEFREE |
Our data suggest that Tollip may play a crucial role in sustaining neuron health by facilitating the completion of autophagy, and that Tollip-deficiency may accelerate neuron death related to neurological disease such as Alzheimer's disease.
|
27720815 |
2017 |
Latent Tuberculosis
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
We also examined the association of TOLLIP variation with BCG-induced T-cell responses and susceptibility to latent tuberculosis infection.
|
28463648 |
2017 |
Necrotizing enterocolitis in fetus OR newborn
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
This study demonstrated B. adolescentis prevents NEC in preterm neonatal rats and that the mechanism for this action might be associated with the alteration of TLR4, TOLLIP, and SIGIRR expression.
|
28056921 |
2017 |
Asthma
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
DNA from blood of asthmatic and normal subjects was genotyped for Tollip SNP rs5743899 AA, AG and GG genotypes.
|
27513438 |
2016 |
Leprosy
|
0.020 |
Biomarker
|
disease |
BEFREE |
Inhibition of TOLLIP may decrease an individual's susceptibility to leprosy and offer a novel therapeutic target for IL-1-dependent diseases.
|
26610735 |
2016 |
Rhinovirus infection
|
0.020 |
Biomarker
|
disease |
BEFREE |
The major goal was to determine the role of genetic variation [e.g. single nucleotide polymorphisms (SNPs)] of Toll-interacting protein (Tollip) in airway epithelial responses to RV in a type 2 cytokine milieu.
|
27513438 |
2016 |
HIV-1 infection
|
0.020 |
Biomarker
|
disease |
BEFREE |
Our data indicate a key role of Tollip in suppressing HIV-1 infection and regulating viral latency, which provides a potential host target for combating HIV-1 infection and latency.
|
27181351 |
2016 |
nervous system disorder
|
0.020 |
Biomarker
|
group |
BEFREE |
However, the role of Tollip in neurological disease remains unknown.
|
26011492 |
2015 |
HIV-1 infection
|
0.020 |
Biomarker
|
disease |
BEFREE |
Further elucidation of the mechanisms by which HIV-1 induces Tollip expression and identification of the role of Tollip in modulating HIV-1 latency will facilitate the understanding of host regulation in viral replication and benefit the exploration of novel strategies for combating HIV-1 infection.
|
25915421 |
2015 |